Biocompatible nanocomposite for PET/MRI hybrid imaging

International Journal of Nanomedicine

Volumn 7, Issue , 2012, Pages 6021-6033

  Locatelli, Erica ^a   Gil, Larraitz ^b   Israel, Liron Limor ^c   Passoni, Lorena ^d,e   Naddaka, Maria ^a   Pucci, Andrea ^a   Reese, Torsten ^b   Gomez Vallejo, Vanessa ^b   Milani, Paolo ^d,e   Matteoli, Michela ^d,f   Llop, Jordi ^b   Lellouche, Jean Paul ^c   Comes Franchini, Mauro ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b CIC BIOMAGUNE   (Spain)

^c BAR ILAN UNIVERSITY   (Israel)

^d UNIVERSITY OF MILAN   (Italy)

^e Fondazione Filarete   (Italy)

^f HUMANITAS CLINICAL AND RESEARCH CENTER   (Italy)

Author keywords

Maghemite nanoparticles; Magnetic resonance imaging; Organic coating; Polymeric nanoparticles; Positron emission tomography; Radiolabeling

Indexed keywords

2,2' [7 [4 [(2 AMINOETHYL)AMINO] 1 CARBOXY 4 OXOBUTYL] 1,4,7 TRIAZONANE 1,4 DIYL]DIACETIC ACID MAGHEMITE 1 POLYETHYLENEGLYCOL BASED NANOPARTICLE; CERIC AMMONIUM NITRATE MAGHEMITE NANOPARTICLE; COPOLYMER; GALLIUM 68; LIGAND; MACROGOL; MAGHEMITE 1 POLYETHYLENEGLYCOL BASED NANOPARTICLE; NANOCOMPOSITE; NANOPARTICLE; NUCLEAR MAGNETIC RESONANCE IMAGING AGENT; ORGANIC COMPOUND; POLYGLACTIN; POLYGLACTIN MACROGOL COPOLYMER; UNCLASSIFIED DRUG; BIOMATERIAL; CONTRAST MEDIUM; DIAGNOSTIC AGENT; GALLIUM; MAGNETITE NANOPARTICLE; NANOMATERIAL; RADIOPHARMACEUTICAL AGENT;

ANIMAL EXPERIMENT; ARTICLE; BIOCOMPATIBILITY; CANCER CELL CULTURE; CANCER DIAGNOSIS; CELL VIABILITY; COMPUTER ASSISTED EMISSION TOMOGRAPHY; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOTOXICITY TEST; DIAGNOSTIC IMAGING; DRUG BLOOD LEVEL; DRUG COATING; DRUG CONJUGATION; DRUG CYTOTOXICITY; DRUG DISTRIBUTION; DRUG SYNTHESIS; DRUG TISSUE LEVEL; EARLY DIAGNOSIS; HUMAN; HUMAN CELL; HYDROPHILICITY; IN VITRO STUDY; IN VIVO STUDY; ISOTOPE LABELING; LIPOPHILICITY; MALE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE RELAXIVITY; PANCREAS ADENOCARCINOMA; POSITRON EMISSION TOMOGRAPHY; RADIOLOGICAL PARAMETERS; RAT; CHEMISTRY; IMAGE ENHANCEMENT; METHODOLOGY; SYNTHESIS;

ANIMALIA;

BIOCOMPATIBLE MATERIALS; CONTRAST MEDIA; GALLIUM RADIOISOTOPES; IMAGE ENHANCEMENT; MAGNETIC RESONANCE IMAGING; MAGNETITE NANOPARTICLES; NANOSTRUCTURES; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS;

EID: 84875835851     PISSN: 11769114     EISSN: 11782013     Source Type: Journal    
DOI: 10.2147/IJN.S38107     Document Type: Article

References (25)

1. Karim-Kos HE, de Vries E, Soerjomataram I, Lemmens V, Siesling S, Coebergh JW. Recent trends of cancer in Europe: a combined approach of incidence, survival and mortality for 17 cancer sites since the 1990s. Eur J Cancer. 2008;44(10):1345-1389.
2. Jemal A, Siegel R, Xu J, Ward E. Cancer statistics, 2010. CA Cancer J Clin. 2010;60(5):277-300.
3. Cheon J, Lee JH. Synergistically integrated nanoparticles as multimodal probes for nanobiotechnology. Acc Chem Res. 2008;41(12): 1630-1640.
4. Corot C, Robert P, Idée JM, Port M. Recent advances in iron oxide nanocrystal technology for medical imaging. Adv Drug Deliv Rev. 2006; 58(14):1471-1504.
5. Moghimi SM, Hunter AC, Murray JC. Long-circulating and targetspecific nanoparticles: theory to practice. Pharmacol Rev. 2001;53(2): 283-318.
6. Haviv AH, Grenèche JM, Lellouche JP. Aggregation control of hydrophilic maghemite (gamma-Fe2O3) nanoparticles by surface doping using cerium atoms. J Am Chem Soc. 2010;132(36):12519-12521.
7. Gref R, Minamitake Y, Peracchia MT, Trubetskoy V, Torchilin V, Langer R. Biodegradable long-circulating polymeric nanospheres. Science. 1994; 263(5153):1600-1603.
8. Cherry SR. Fundamentals of positron emission tomography and applications in preclinical drug development. J Clin Pharmacol. 2001;41(5): 482-491.
9. Bond-Smith G, Banga N, Hammond TM, Imber CJ. Pancreatic adenocarcinoma. BMJ. 2012;344:e2476.
10. Zafar SF, El-Rayes BF. Chemotherapeutic strategies in advanced or metastatic pancreatic adenocarcinoma. Am J Clin Oncol. Epub May 24, 2012.
11. Esman N, Haviv A, Lellouche JP. Magnetically responsive polypyrrole nanotubes using Ce(III)-stabilized maghemite nanoparticles. Nanotechnology. 2011;22(28):285604.
12. Yuen AK, Hutton GA, Masters AF, Maschmeyer T. The interplay of catechol ligands with nanoparticulate iron oxides. Dalton Trans. 2012;41(9):2545-2559.
13. Comes Franchini M, Baldi G, Bonacchi D, et al. Bovine serum albumin-based magnetic nanocarrier for MRI diagnosis and hyperthermic therapy: a potential theranostic approach against cancer. Small. 2010;6(3):366-370.
14. Baldi G, Bonacchi D, Franchini MC, et al. Synthesis and coating of cobalt ferrite nanoparticles: a first step toward the obtainment of new magnetic nanocarriers. Langmuir. 2007;23(7):4026-4028.
15. Comes Franchini M, Bonini BF, Camaggi CM, et al. Design and synthesis of novel 3,4-disubstituted pyrazoles for nanomedicine applications against malignant gliomas. Eur J Med Chem. 2010;45(5): 2024-2033.
16. Cheng J, Teply BA, Sherifi I, et al. Formulation of functionalized PLGA- PEG nanoparticles for in vivo targeted drug delivery. Biomaterials. 2007;28(5):869-876.
17. Lewinski N, Colvin V, Drezek R. Cytotoxicity of nanoparticles. Small. 2008;4(1):26-49.
18. Kukis DL, Diril H, Greiner DP, et al. A comparative study of copper-67 radiolabeling and kinetic stabilities of antibody-macrocycle chelate conjugates. Cancer. 1994;73(Suppl 3):779-786.
19. Boswell CA, Sun X, Niu W, et al. Comparative in vivo stability of copper-64-labeled cross-bridged and conventional tetraazamacrocyclic complexes. J Med Chem. 2004;47(6):1465-1474.
20. Huang X, Zhang F, Lee S, et al. Long-term multimodal imaging of tumor draining sentinel lymph nodes using mesoporous silica-based nanoprobes. Biomaterials. 2012;33(17):4370-4378.
21. Ko HY, Choi KJ, Lee CH, Kim S. A multimodal nanoparticlebased cancer imaging probe simultaneously targeting nucleolin, integrin αvβ3 and tenascin-C proteins. Biomaterials. 2011;32(4): 1130-1138.
22. Matarrese M, Bedeschi P, Scardaoni R, et al. Automated production of copper radioisotopes and preparation of high specific activity [(64)Cu] Cu-ATSM for PET studies. Appl Radiat Isot. 2010;68(1):5-13.
23. Velikyan I, Beyer GJ, Långström B. Microwave-supported preparation of (68)Ga bioconjugates with high specific radioactivity. Bioconjug Chem. 2004;15(3):554-560.
24. Moghimi SM, Hunter AC, Andresen TL. Factors controlling nanoparticle pharmacokinetics: an integrated analysis and perspective. Annu Rev Pharmacol Toxicol. 2012;52:481-503.
25. Kaiser E, Colescott RL, Bossinger CD, Cook PI. Color test for detection of free terminal amino groups in the solid-phase synthesis of peptides. Anal Biochem. 1970;34(2):595-598.